Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
Background. Treatment of patients with advanced cancers of the female reproductive system is very challenging. The most common treatment scheme for such patients includes paclitaxel 135-175 mg/m2 + carboplatin AUC 5-6 or cisplatin 75 mg/m2. However, lengthy treatment with this regimen is limited by...
Saved in:
Main Authors: | A. G. Kedrova (Author), S. E. Krasilnikov (Author), D. A. Astakhov (Author), V. V. Kosyy (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anemia in patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019) -
The role of topotecan in cancer ginecology treatment
by: A. G. Kedrova, et al.
Published: (2017) -
Chemoembolization with HepaSpheres in the treatment of recurrent pelvic tumors
by: A. G. Kedrova, et al.
Published: (2019) -
Prevention of vaginal atrophy after treatment for tumors of the female reproductive system
by: A. G. Kedrova
Published: (2020) -
Chemoembolization with HepaSpheres as a stage of comprehensive treatment for malignant pelvic tumors
by: A. G. Kedrova, et al.
Published: (2019)